News About: Pharm. Industry
Rapid increase of bioequivalently proven medicines, what is the reason?
The number of medicines bioequivalently proven this year was 157 products, reportedly increased by 58%.
The phenomenon was caused by the fact the Korean pharmaceutical companies have been active in developing generic...
Kolmar Korea to bring an upheaval in pharma industry with acquisition of CJ HealthCare
Kolmar Korea, a global cosmetic ODM(Original Design Manufacturer) company and the top CMO(Contract Manufacturing Organization) in Korea, will acquire the pharmaceutical company under CJ Group, CJ HealthCare. The acqui...
Pharmaceutical industry caught two hares at once
While recording a huge growth both in quality and quantity with 32% increased employees only in 10 years, the Korean pharmaceutical industry was analyzed to have a bright future ahead as having increases in all the ca...
Celltrion acquires approval of ‘Herzuma’ in Europe
Celltrion announced Herzuma(CT-P6, generic name: Trastuzumab), an antibody biosimilar for the treatment of breast cancer, acquired approval from the European Medicines Agency(EMA) on the 13th(local time). The EMA gave...
Yuhan & Daewoong to KRW 2 trillion sales, Hanmi for virtuous cycle in R&D investment
Pharmaceutical companies are running energetically towards their 2020 goals.
Their goals, which foresee how they will perform in 3 years, vary: KRW 2 trillion sales, KRW 1 trillion sales, establishment of virtuous ci...
Chair-Elect Jung-Hee Lee, “I’ll openly communicate with members”Yuhan Corporation President Jung-Hee Lee, a person who was elected as the next Chair of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA), said he would m...
|
KPBMA, ‘Raising the Pharmaceutical & Biotechnology Industries’ Status as National Industry’
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) set ‘Raising the Pharmaceutical & Biotechnology Industries’ Status as National Industry’ as the 2018 business goal.
In order to achieve the goa...
Most term-expiring professional managers at listed pharmaceutical companies are likely to remain in office
Most professional managers at listed pharmaceutical companies, who will finish their term of office, seem to remain in office.
According to the pharmaceutical industry, professional managers at 15 listed pharmaceutic...
SK Chemicals and Sanofi Pasteur sign license agreement of ‘cell culture technology’The SK Chemicals’ technological level has once been recognized by the world as the company exported its vaccine manufacturing technology to a global pharmaceutical company.
SK ...
|
Spread of words about prosecution investigating rebates either February and March
The pharmaceutical industry has started to concern about rebate inspections once again. This is because the concern is connected to a personnel reshuffle at the Seoul Western District(SWD) Prosecutors’ Office which ha...
